Skip to content

Dermatological Abnormalities in Beta-thalassemia Major

Assessment ofDermatological Abnrmalities in Beta-thalassemia Major in Assiut University Pediatric Hospital

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03894605
Enrollment
125
Registered
2019-03-28
Start date
2020-03-02
Completion date
2021-04-02
Last updated
2019-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Beta-Thalassemia

Brief summary

to study the frequency and pattern of dermatological abnormalities in egyptian childern with beta thalassemia.relationof abnormalities to duration of disease and frequency of transfusion

Detailed description

thalassemia refers to agroup of inherited disease characterized by decreased or absent synthesis of normal globin .skinvdisorders are usually neglected and frequently underdiagnosed among these patients.skin disease specially pruritus and xerosis are observed highly frequently in patients with beta-thalassemia.pityriasis alba is arelatively common skin disorder.the trophic skin changes and leg ulcers occurred after the age of 15 years

Interventions

DEVICEthalassemia

thalassemic patient use chelator and thaladssemic patient with frequent blood transfusion

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
2 Years to 18 Years
Healthy volunteers
Yes

Inclusion criteria

Inclusio2n Criteria: * clinical diagnosis of dermatological abnormalities in thalassemic patient. must be on chelator

Exclusion criteria

* patient with other hemolytic anemia. childern with any abnormalities prior to the diagnosis of thalassemi

Design outcomes

Primary

MeasureTime frameDescription
The percentage of patients with dermatological disorders due to iron overload Iron overload cause dermatological abnormalitiesone monththe number of patients who develop any dermatological disorder as a result of iron overload after frequent blood transfusion

Contacts

Primary ContactAlsayed khalil Abd elkareem, Professor
Khalilsay@gmail.com01060805170
Backup ContactMostafa Mohamed, Lecturer
Mustafa-embaby@aun.edu.eg01006244311

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026